Financials
- Market Capitalization 585.74 M
- Employee 200
- Founded 2015
- CEO N/A
- Website www.ars-pharma.com
- Headquarter Delaware, United States
- FIGI BBG00FZQGXG3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.69
ratio cours/chiffre d'affaires
6.78
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2800 | ALT Altimmune, Inc. - Common Stock | 3.11 USD | -4.01% | 0.00% | +7.99% | -18.37% | 604.95 M USD | ||
| 2808 | ARVN Arvinas, Inc. - Common Stock | 9.18 USD | -0.65% | -2.13% | +13.33% | -1.29% | 600.25 M USD | ||
| 2831 | MPLT MapLight Therapeutics, Inc. - Common Stock | 12.60 USD | +0.48% | +12.40% | -1.95% | -33.68% | 584.36 M USD | ||
| 2855 | VALN Valneva SE - American Depositary Shares | 6.43 USD | -2.28% | -3.74% | +26.08% | -20.22% | 557.93 M USD |